POEMS Syndrome: Therapeutic Options

Area of Science:

• Hematology
• Neurology
• Oncology

Background:

• POEMS syndrome is a rare multisystem disorder associated with a specific plasma cell clone.
• Effective treatment necessitates targeting the underlying neoplastic plasma cells.

Purpose of the Study:

• To outline risk-adapted therapeutic strategies for POEMS syndrome.
• To highlight the role of novel agents in managing this condition.

Main Methods:

• Review of current treatment paradigms for POEMS syndrome.
• Evaluation of therapeutic responses based on disease extent and patient characteristics.

Main Results:

• Radiation therapy is effective for localized POEMS syndrome with limited bone lesions and no bone marrow involvement.
• High-dose chemotherapy with autologous stem cell transplantation is preferred for disseminated disease.
• Novel agents, including lenalidomide, show promise and can be used before or with other therapies for rapid neurologic responses.

Conclusions:

• Therapy for POEMS syndrome should be individualized based on disease burden and patient factors.
• Lenalidomide represents a promising option for achieving rapid neurologic improvement in POEMS syndrome patients.